All Stories

  1. Reporting patterns of adverse drug withdrawal events using individual case safety reports in United States and European databases

    Article • June 2026, openRxiv

    Frank Moriarty

  2. Prescription intervals of medications for chronic use: a cohort study

    Article • June 2026, openRxiv

    Frank Moriarty

  3. Strengthening Pharmacovigilance Reporting for Withdrawal Reactions to Support Deprescribing

    Article • Clinical Pharmacology & Therapeutics, June 2026, Wiley

    Frank Moriarty

  4. Avoiding being the “busy fool”: How general practitioners perceive and engage with a prescribing safety and quality dashboard

    Article • May 2026, openRxiv

    Frank Moriarty

  5. An ageing biomarker signature predicts chronic disease cluster trajectories, physical function and mortality: validation in the TILDA and HRS cohorts

    Article • Age and Ageing, May 2026, Oxford University Press (OUP)

    Frank Moriarty

  6. Trends in the Chronic Use and Discontinuation of Potentially Inappropriate Medications in Older Adults

    Article • Journal of the American Geriatrics Society, March 2026, Wiley

    Frank Moriarty

  7. Characterising prescribing cascades in older community-dwelling adults attending general practice in The Netherlands: a retrospective cohort study

    Article • BMC Primary Care, March 2026, Springer Science + Business Media

    Frank Moriarty

  8. An essential medicines list in Ireland: A qualitative interview study of interest-holders

    Article • Health Policy, March 2026, Elsevier

    Frank Moriarty

  9. Adverse Drug Reaction-Related Hospital Admissions and Adverse Drug Events and Their Association with Short- and Long-Term Health Outcomes in Older Adults

    Article • Geriatrics, January 2026, MDPI AG

    Frank Moriarty

  10. A Methodological Review of Simulation Studies Published in Pharmacoepidemiology and Drug Safety

    Article • Pharmacoepidemiology and Drug Safety, January 2026, Wiley

    Frank Moriarty

  11. Identifying core teamwork competencies for community-based health and social care professionals: an e-Delphi study

    Article • BMC Medical Education, January 2026, Springer Science + Business Media

    Frank Moriarty

  12. Analysing the impact of complex multimorbidity on health-related quality of life

    Article • Quality of Life Research, January 2026, Springer Science + Business Media

    Frank Moriarty

  13. Prevalence and impact of prescribing cascades in community‐dwelling adults: Longitudinal analysis of the Irish longitudinal study on ageing (TILDA)

    Article • British Journal of Clinical Pharmacology, December 2025, Wiley

    Frank Moriarty

  14. The association between STOPPFall medication use and orthostatic hypotension in community-dwelling older people

    Article • Age and Ageing, November 2025, Oxford University Press (OUP)

    Frank Moriarty

  15. Identifying outcomes for evaluating the impact of pharmacist prescribing: A rapid overview of reviews.

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Frank Moriarty

  16. Changes in benzodiazepine, z-drug, and other sedative prescribing in primary care in Ireland between 2014 and 2022

    Article • Family Practice, October 2025, Oxford University Press (OUP)

    Frank Moriarty

  17. Potentially inappropriate prescribing and falls-risk increasing drugs in people who have experienced a fall: a systematic review and meta-analysis

    Article • Age and Ageing, August 2025, Oxford University Press (OUP)

    Frank Moriarty

  18. An essential medicines list in Ireland: A qualitative interview study of interest-holders

    Article • August 2025, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  19. Pharmaceutical company promotional payments to English general practices: longitudinal study

    Article • BJGP Open, August 2025, Royal College of General Practitioners

    Frank Moriarty

  20. Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022: A repeated cross‐sectional study

    Article • British Journal of Clinical Pharmacology, August 2025, Wiley

    Frank Moriarty

  21. Identifying predictors of medication-related harm in older populations: a latent class analysis approach

    Article • Age and Ageing, August 2025, Oxford University Press (OUP)

    Frank Moriarty

  22. Medicines support and socIal prescribing to aDdress pAtient prioritieS in multimorbidity (MIDAS): A process evaluation protocol

    Article • HRB Open Research, July 2025, Faculty of 1000, Ltd.

    Frank Moriarty

  23. The healthcare costs of poor air quality in Ireland: A review of potential data sources and methods

    Article • June 2025, Economic and Social Research Institute

    Frank Moriarty

  24. Developing and assessing the usability of a prescribing quality and safety dashboard in Irish general practice: protocol for a qualitative study

    Article • HRB Open Research, June 2025, Faculty of 1000, Ltd.

    Frank Moriarty

  25. Effectiveness of interactive dashboards to optimize prescribing in general practice: a systematic review

    Article • Family Practice, June 2025, Oxford University Press (OUP)

    Frank Moriarty

  26. Impact of eliciting treatment priorities on analgesic prescribing in older patients with high levels of polypharmacy

    Article • Family Practice, June 2025, Oxford University Press (OUP)

    Frank Moriarty

  27. Medicines support and social prescribing to address patient priorities in multimorbidity (MIDAS): protocol for a definitive, multi-arm, cluster randomised, controlled trial in Irish general practice

    Article • BMJ Open, June 2025, BMJ

    Frank Moriarty

  28. RxTrends: An R-based Shiny Application for Visualising Open Data on Prescribed Medications in Ireland

    Article • HRB Open Research, May 2025, Faculty of 1000, Ltd.

    Frank Moriarty

  29. Added Therapeutic Benefits of Top‐Selling Drugs in Japan: A Cross‐Sectional Study Using Health Technology Assessment

    Article • Clinical and Translational Science, May 2025, Wiley

    Frank Moriarty, PhD Hideki Maeda

  30. Pharmacoepidemiology simulation study practices: A methodological review

    Article • May 2025, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  31. The association between STOPPFall medication use and falls and fractures in community-dwelling older people

    Article • Age and Ageing, May 2025, Oxford University Press (OUP)

    Frank Moriarty

  32. Shortcomings in reporting country-level participation in multicenter randomized controlled trials involving Ireland as a collaborating partner: a metaresearch study

    Article • Journal of Clinical Epidemiology, May 2025, Elsevier

    Frank Moriarty

  33. Prevalence of potentially inappropriate prescribing in community-dwelling older adults: an application of STOPP/START version 3 to The Irish Longitudinal Study on Ageing (TILDA)

    Article • European Geriatric Medicine, April 2025, Springer Science + Business Media

    Frank Moriarty

  34. Potentially inappropriate prescribing and falls-risk increasing drugs in people who have experienced a fall; a systematic review and meta-analysis

    Article • April 2025, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  35. Out-of-pocket prescription medicine expenditure amongst community-dwelling adults: Findings from the Irish longitudinal study on ageing (TILDA) in 2016

    Article • Exploratory Research in Clinical and Social Pharmacy, March 2025, Elsevier

    Frank Moriarty

  36. RxTrends: An R-based Shiny Application for Visualising Open Data on Prescribed Medications in Ireland

    Article • HRB Open Research, February 2025, Faculty of 1000, Ltd.

    Frank Moriarty

  37. Use of complementary and alternative medicine (CAM) among people living with Sjögren’s: a cross-sectional survey using a modified international CAM questionnaire (I-CAM-Q)

    Article • Rheumatology International, February 2025, Springer Science + Business Media

    Frank Moriarty

  38. Effectiveness of interactive dashboards to optimise prescribing in primary care: a protocol for a systematic review

    Article • HRB Open Research, February 2025, Faculty of 1000, Ltd.

    Frank Moriarty

  39. Evaluating the impact of general practice pharmacist‐led person‐centred medicines reviews on medicines appropriateness and patient‐reported outcome measures

    Article • British Journal of Clinical Pharmacology, February 2025, Wiley

    Frank Moriarty

  40. Associations between pharmaceutical industry interactions and prescribing practices in chronic non-malignant pain management: A protocol for a systematic review

    Article • HRB Open Research, January 2025, Faculty of 1000, Ltd.

    Frank Moriarty

  41. Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults

    Article • January 2025, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  42. Adverse drug reactions and events in an Ageing PopulaTion risk Prediction (ADAPTiP) tool: the development and validation of a model for predicting adverse drug reactions and events in older patients

    Article • European Geriatric Medicine, January 2025, Springer Science + Business Media

    Frank Moriarty

  43. Prevalence and predictors of sub-optimal laboratory monitoring of selected higher risk medicines in Irish general practice: a 5-year retrospective cohort study of community-dwelling older adults

    Article • BMJ Open, January 2025, BMJ

    Frank Moriarty

  44. Development and Implementation of Deprescribing Guidelines

    Article • January 2025, Springer Science + Business Media

    Frank Moriarty

  45. Optimising Medication Therapy in Older People

    Article • January 2025, Springer Science + Business Media

    Frank Moriarty

  46. Core medication use in general practice prescriptions: A pilot study evaluating the Drug Utilization 90% Index in Irish general practice

    Article • British Journal of Clinical Pharmacology, December 2024, Wiley

    Frank Moriarty

  47. Trends and patterns of sedative prescribing in primary care in Ireland between 2014 and 2022 - a repeated cross-sectional study

    Article • November 2024, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  48. Potentially inappropriate prescribing in middle-aged adults: a significant problem with a lack of action and evidence to address it

    Article • BJGP Open, November 2024, Royal College of General Practitioners

    Frank Moriarty

  49. The Association Between Psychotropic Medication Use and Gait and Mobility Impairment in Community-Dwelling Older People: Data From The Irish Longitudinal Study on Ageing (TILDA)

    Article • The Journals of Gerontology Series A, November 2024, Oxford University Press (OUP)

    Frank Moriarty

  50. Evaluation of real-world evidence to assess health outcomes related to deprescribing medications in older adults: an International Society for Pharmacoepidemiology–endorsed systematic review of methodology

    Article • American Journal of Epidemiology, November 2024, Oxford University Press (OUP)

    Frank Moriarty

  51. Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015 and 2019: A content analysis

    Article • Health Policy, November 2024, Elsevier

    Frank Moriarty

  52. Patterns of pain medication usage and self-reported pain in older Irish adults with osteoarthritis: A latent class analysis of data from the Irish Longitudinal Study on Ageing

    Article • BMC Musculoskeletal Disorders, October 2024, Springer Science + Business Media

    Frank Moriarty

  53. Time Trends, Regional Variation and Associations of Low‐Allergy Formula Prescribing in England

    Article • Clinical & Experimental Allergy, September 2024, Wiley

    Frank Moriarty

  54. Medication adherence for people with acquired communication disorders: A systematic review

    Article • British Journal of Clinical Pharmacology, September 2024, Wiley

    Frank Moriarty

  55. Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Residents of Long-Term Care Facilities

    Article • Journal of the American Medical Directors Association, September 2024, Elsevier

    Frank Moriarty, Associate Professor Ravi Bhat

  56. Cost effectiveness of a GP delivered medication review to reduce polypharmacy and potentially inappropriate prescribing in older patients with multimorbidity in Irish primary care: the SPPiRE cluster randomised controlled trial

    Article • The European Journal of Health Economics, August 2024, Springer Science + Business Media

    Frank Moriarty

  57. Effectiveness of interactive dashboards to optimise prescribing in general practice: A systematic review

    Article • August 2024, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  58. Out-of-pocket prescription medicine expenditure amongst community-dwelling adults: findings from The Irish Longitudinal Study on Ageing (TILDA) in 2016

    Article • July 2024, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  59. The Development of Principles for Patient and Public Involvement (PPI) in Preclinical Spinal Cord Research: A Modified Delphi Study

    Article • Health Expectations, July 2024, Wiley

    Frank Moriarty

  60. Effectiveness of interactive dashboards to optimise prescribing in primary care: a protocol for a systematic review

    Article • HRB Open Research, July 2024, Faculty of 1000, Ltd.

    Frank Moriarty

  61. Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals

    Article • Clinical and Translational Science, July 2024, Wiley

    Frank Moriarty

  62. Prevalence and risk factors for milk allergy overdiagnosis in the BEEP trial cohort

    Article • Allergy, June 2024, Wiley

    Frank Moriarty

  63. Evaluating time to withdrawal of anti-cancer drug indications that received FDA’s accelerated approval

    Article • QJM, June 2024, Oxford University Press (OUP)

    Frank Moriarty

  64. Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022 - a repeated cross-sectional study

    Article • June 2024, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  65. Stakeholder perceptions of and attitudes towards problematic polypharmacy and prescribing cascades: a qualitative study

    Article • Age and Ageing, June 2024, Oxford University Press (OUP)

    Frank Moriarty

  66. Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: An observational study

    Article • Health Policy and Technology, June 2024, Elsevier

    Frank Moriarty

  67. Adverse Drug reactions in an Ageing PopulaTion risk Prediction (ADAPTiP) tool: the development of a model for predicting adverse drug reaction-related hospital admissions in older patients

    Article • May 2024, Wiley

    Frank Moriarty

  68. What do clinical practice guidelines say about deprescribing? A scoping review

    Article • BMJ Quality & Safety, May 2024, BMJ

    Frank Moriarty

  69. Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks

    Article • Expert Review of Clinical Pharmacology, May 2024, Taylor & Francis

    Frank Moriarty

  70. Measuring Quality of Life in Deprescribing Trials: A Scoping Review

    Article • Drugs & Aging, May 2024, Springer Science + Business Media

    Frank Moriarty

  71. Epidemiology and management of oral cavity squamous cell carcinoma in Ireland

    Article • American Journal of Otolaryngology, May 2024, Elsevier

    Frank Moriarty

  72. The role of Patient and public involvement (PPI) in pre-clinical spinal cord research: An interview study

    Article • PLOS One, April 2024, PLOS

    Frank Moriarty

  73. Primary care prescribing prior to lung cancer diagnosis (PPP-Lung): protocol for a systematic review

    Article • HRB Open Research, April 2024, Faculty of 1000, Ltd.

    Frank Moriarty

  74. Pediatric blood cultures—turning up the volume: a before and after intervention study

    Article • European Journal of Pediatrics, April 2024, Springer Science + Business Media

    Frank Moriarty

  75. Drug company methodologies used for reporting in the UK pharmaceutical industry payment transparency database between 2015-2019: A content analysis

    Article • April 2024, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  76. Paediatric Escherichia coli urinary tract infection: susceptibility trends and clinical management—a retrospective analysis of a 10-year period

    Article • Irish Journal of Medical Science (1971 -), April 2024, Springer Science + Business Media

    Frank Moriarty

  77. Challenges in identifying and quantifying country-level participation in multi-country randomised controlled trials involving Ireland as a collaborating partner

    Article • March 2024, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  78. Perspectives of researchers and clinicians on patient and public involvement (PPI) in preclinical spinal cord research: An interview study

    Article • Health Expectations, January 2024, Wiley

    Frank Moriarty

  79. Potentially Inappropriate Prescribing and Potential Prescribing Omissions and Their Association with Adverse Drug Reaction-Related Hospital Admissions

    Article • Journal of Clinical Medicine, January 2024, MDPI AG

    Frank Moriarty

  80. Drug–drug interactions and the risk of adverse drug reaction‐related hospital admissions in the older population

    Article • British Journal of Clinical Pharmacology, December 2023, Wiley

    Frank Moriarty

  81. Trends in medication use at the onset of and during the COVID‐19 pandemic in the Republic of Ireland: An interrupted time series study

    Article • Basic & Clinical Pharmacology & Toxicology, November 2023, Wiley

    Frank Moriarty

  82. Prescribing differences among older adults with differing health cover and socioeconomic status: a cohort study

    Article • BMC Geriatrics, November 2023, Springer Science + Business Media

    Frank Moriarty

  83. Medication Adherence for People with Acquired Communication Disorders: A Systematic Review

    Article • November 2023, Wiley

    Frank Moriarty

  84. Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2016-2021: A methodological report

    Article • HRB Open Research, October 2023, Faculty of 1000, Ltd.

    Frank Moriarty

  85. Effect of COVID-19 vaccines for the treatment of people with post-COVID-19 condition: a rapid review

    Article • HRB Open Research, October 2023, Faculty of 1000, Ltd.

    Frank Moriarty

  86. Perspectives of Researchers and Clinicians on Patient and Public Involvement (PPI) in Preclinical Spinal Cord Research: An Interview Study

    Article • August 2023, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  87. The role of Patient and Public Involvement (PPI) in pre-clinical spinal cord research: an interview study

    Article • July 2023, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  88. Potentially inappropriate prescribing in middle-aged adults: A significant problem with a lack of action and evidence to address it.

    Article • July 2023, Wiley

    Frank Moriarty

  89. Survival in an era of organ preservation: an update on laryngeal cancer in Ireland

    Article • European Archives of Oto-Rhino-Laryngology, June 2023, Springer Science + Business Media

    Frank Moriarty

  90. Trends in medication use after the onset of the COVID-19 pandemic in the Republic of Ireland: an interrupted time series study

    Article • June 2023, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  91. Use of pharmacy services in community-dwelling middle-aged and older adults; findings from The Irish Longitudinal Study on Ageing (TILDA)

    Article • Exploratory Research in Clinical and Social Pharmacy, June 2023, Elsevier

    Frank Moriarty

  92. The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in Europe

    Article • British Journal of Clinical Pharmacology, May 2023, Wiley

    Frank Moriarty

  93. Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional studies

    Article • Basic & Clinical Pharmacology & Toxicology, May 2023, Wiley

    Frank Moriarty

  94. Clinical study reports published by the European Medicines Agency 2016–2018: a cross-sectional analysis

    Article • BMJ Open, May 2023, BMJ

    Frank Moriarty

  95. A blended model to support brief interventions in primary care: A qualitative study of usability and acceptability of HealthEir in community pharmacy

    Article • Research in Social and Administrative Pharmacy, May 2023, Elsevier

    Frank Moriarty

  96. Payments to healthcare organisations reported by the medical device industry in Europe from 2017 to 2019: an observational study

    Article • April 2023, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  97. The association between weather warnings and hip fractures in the Republic of Ireland

    Article • Archives of Osteoporosis, April 2023, Springer Science + Business Media

    Frank Moriarty

  98. Recruiting general practitioners and older patients with multimorbidity to randomized trials

    Article • Family Practice, April 2023, Oxford University Press (OUP)

    Frank Moriarty

  99. Prescribing differences among older adults with differing health cover and socioeconomic status: a cohort study

    Article • April 2023, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  100. Association between patient attitudes towards deprescribing and subsequent prescription changes

    Article • Basic & Clinical Pharmacology & Toxicology, March 2023, Wiley

    Frank Moriarty

  101. Use of pharmacy services in community-dwelling middle-aged and older adults; findings from The Irish Longitudinal Study on Ageing (TILDA)

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  102. Formal health care costs among older people in Ireland: methods and estimates using The Irish Longitudinal Study on Ageing (TILDA)

    Article • HRB Open Research, March 2023, Faculty of 1000, Ltd.

    Frank Moriarty

  103. The impact of lidocaine plaster prescribing reduction strategies: a comparison of two national health services in Europe

    Article • February 2023, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  104. Value assessment of deprescribing interventions: Suggestions for improvement

    Article • Journal of the American Geriatrics Society, February 2023, Wiley

    Frank Moriarty

  105. Deprescribing and medicines optimisation, two sides of the same coin? Considerations for design of interventional studies

    Article • February 2023, Wiley

    Frank Moriarty

  106. The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: a systematic review

    Article • BMC Primary Care, February 2023, Springer Science + Business Media

    Frank Moriarty

  107. Association between patient attitudes towards deprescribing and subsequent prescription changes

    Article • January 2023, Wiley

    Frank Moriarty

  108. The effectiveness and cost of integrating pharmacists within general practice to optimize prescribing and health outcomes in primary care patients with polypharmacy: A systematic review

    Article • December 2022, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  109. Is There Evidence of an Association Between Acute Health Care Utilization and Function in Older Adults Over Time? A Population-Based Cohort Study

    Article • Innovation in Aging, December 2022, Oxford University Press (OUP)

    Frank Moriarty, Dominic Trépel

  110. Key items for reports of primary care research: an international Delphi study

    Article • BMJ Open, December 2022, BMJ

    Frank Moriarty

  111. Medication safety incidents associated with the remote delivery of primary care: a rapid review

    Article • International Journal of Pharmacy Practice, December 2022, Oxford University Press (OUP)

    Frank Moriarty

  112. Overprescribing among older people near end of life in Ireland: Evidence of prevalence and determinants from The Irish Longitudinal Study on Ageing (TILDA)

    Article • PLOS One, November 2022, PLOS

    Frank Moriarty

  113. Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy

    Article • International Journal of Clinical Pharmacy, November 2022, Springer Science + Business Media

    Frank Moriarty

  114. Adverse drug reactions and associated patient characteristics in older community-dwelling adults: a 6-year prospective cohort study

    Article • British Journal of General Practice, October 2022, Royal College of General Practitioners

    Frank Moriarty

  115. Effect of COVID-19 vaccines for the treatment of people with post-COVID-19 condition: a rapid review

    Article • HRB Open Research, October 2022, Faculty of 1000, Ltd.

    Frank Moriarty

  116. Eligibility rates and representativeness of the General Medical Services scheme population in Ireland 2017-2021: A methodological report

    Article • HRB Open Research, October 2022, Faculty of 1000, Ltd.

    Frank Moriarty

  117. Patient and general practitioner experiences of implementing a medication review intervention in older people with multimorbidity: Process evaluation of the SPPiRE trial

    Article • Health Expectations, October 2022, Wiley

    Frank Moriarty

  118. Direct-to-consumer genetic testing: an updated systematic review of healthcare professionals’ knowledge and views, and ethical and legal concerns

    Article • European Journal of Human Genetics, October 2022, Springer Science + Business Media

    Frank Moriarty

  119. Prescribing cascades in community‐dwelling adults: A systematic review

    Article • Pharmacology Research & Perspectives, September 2022, Wiley

    Frank Moriarty

  120. Evaluation of policies and practices to support safe and appropriate analgesic and sedative prescribing: The CDRx (controlled drug prescribing) protocol

    Article • Research in Social and Administrative Pharmacy, September 2022, Elsevier

    Frank Moriarty

  121. What is the impact of multimorbidity on out-of-pocket healthcare expenditure among community-dwelling older adults in Ireland? A cross-sectional study

    Article • BMJ Open, September 2022, BMJ

    Frank Moriarty

  122. Medication changes  and potentially inappropriate prescribing in older patients with significant  polypharmacy: a secondary analysis of the SPPiRE trial            

    Article • July 2022, Wiley

    Frank Moriarty

  123. Prescribing cascades in community-dwelling adults: a systematic review

    Article • June 2022, Wiley

    Frank Moriarty

  124. Prescribing trends in older patients with multimorbidity and significant polypharmacy recruited to the SPPiRE trial

    Article • May 2022, Wiley

    Frank Moriarty

  125. Development of the ADFICE_IT Models for Predicting Falls and Recurrent Falls in Community-Dwelling Older Adults: Pooled Analyses of European Cohorts With Special Attention to Medication

    Article • The Journals of Gerontology Series A, April 2022, Oxford University Press (OUP)

    Frank Moriarty

  126. Hospital initiation of benzodiazepines and Z-drugs in older adults and discontinuation in primary care

    Article • Research in Social and Administrative Pharmacy, April 2022, Elsevier

    Frank Moriarty

  127. Cost outcomes of potentially inappropriate prescribing in middle‐aged adults: A Delphi consensus and cross‐sectional study

    Article • British Journal of Clinical Pharmacology, March 2022, Wiley

    Frank Moriarty

  128. Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data

    Article • Research in Social and Administrative Pharmacy, February 2022, Elsevier

    Frank Moriarty

  129. GP-delivered medication review of polypharmacy, deprescribing, and patient priorities in older people with multimorbidity in Irish primary care (SPPiRE Study): A cluster randomised controlled trial

    Article • PLoS Medicine, January 2022, PLOS

    Frank Moriarty

  130. A systematic review of the prevalence, determinants, and impact of potentially inappropriate prescribing in middle-aged adults

    Article • Drugs & Therapy Perspectives, January 2022, Springer Science + Business Media

    Frank Moriarty

  131. ‘More of an art than a science’? The development, design and mechanics of the Delphi Technique

    Article • Research in Social and Administrative Pharmacy, January 2022, Elsevier

    Frank Moriarty

  132. Opioid and analgesic utilization in Ireland in 2000 and 2015: A repeated cross‐sectional study

    Article • Pharmacology Research & Perspectives, December 2021, Wiley

    Frank Moriarty

  133. Prescribing cascades in community-dwelling adults: protocol for a systematic review

    Article • HRB Open Research, September 2021, Faculty of 1000, Ltd.

    Frank Moriarty

  134. Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis

    Article • Hypertension, September 2021, Wolters Kluwer Health

    Frank Moriarty

  135. GPs’ perceptions of their relationship with the pharmaceutical industry: a qualitative study

    Article • BJGP Open, August 2021, Royal College of General Practitioners

    Frank Moriarty

  136. Prescribing cascades in community-dwelling adults: protocol for a systematic review

    Article • HRB Open Research, July 2021, Faculty of 1000, Ltd.

    Frank Moriarty

  137. Age alone is not a barrier to concurrent chemoradiotherapy for advanced head and neck cancer

    Article • May 2021, Wiley

    Frank Moriarty

  138. Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland

    Article • Archives of Osteoporosis, April 2021, Springer Science + Business Media

    Frank Moriarty

  139. Efficacy and safety of sacubitril/valsartan in the treatment of heart failure: protocol for a systematic review incorporating unpublished clinical study reports

    Article • HRB Open Research, April 2021, Faculty of 1000, Ltd.

    Frank Moriarty

  140. Prognostic Significance of Glucocorticoid Receptor Expression in Cancer: A Systematic Review and Meta-Analysis

    Article • Cancers, April 2021, MDPI AG

    Frank Moriarty

  141. How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England

    Article • BMJ Open, March 2021, BMJ

    Frank Moriarty

  142. Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study

    Article • British Journal of General Practice, February 2021, Royal College of General Practitioners

    Frank Moriarty

  143. Cognitive decline associated with anticholinergics, benzodiazepines and Z‐drugs: Findings from The Irish Longitudinal Study on Ageing (TILDA)

    Article • British Journal of Clinical Pharmacology, December 2020, Wiley

    Frank Moriarty

  144. Factors associated with initiation of bone-health medication among older adults in primary care in Ireland

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  145. Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  146. Aspirin prescribing in cardiovascular disease in middle-aged and older adults in Ireland: findings from The Irish Longitudinal Study on Ageing

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  147. Hospital initiation of benzodiazepines and Z-drugs in older adults and discontinuation in primary care

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  148. How many medications do doctors in primary care use? An observational study of the DU90% indicator in primary care in England.

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  149. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study

    Article • BMJ Open, June 2020, BMJ

    Frank Moriarty

  150. Cognitive decline associated with anticholinergics, benzodiazepines, and Z-drugs: findings from The Irish Longitudinal Study on Ageing (TILDA)

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  151. Pharmacists in general practice: a qualitative process evaluation of the General Practice Pharmacist (GPP) study

    Article • Family Practice, May 2020, Oxford University Press (OUP)

    Frank Moriarty

  152. The Development of an Accreditation Framework for Continuing Education Activities for Pharmacists

    Article • Pharmacy, April 2020, MDPI AG

    Frank Moriarty

  153. High-risk categories for COVID-19 and their distribution by county in Republic of Ireland-evidence from the TILDA study

    Article • April 2020, The Irish Longitudinal Study on Ageing

    Frank Moriarty, Dr Christine McGarrigle

  154. TILDA report to inform demographics for over 50s in Ireland for COVID-19 crisis

    Article • March 2020, The Irish Longitudinal Study on Ageing

    Frank Moriarty, Dr Christine McGarrigle

  155. Efficacy and safety of sacubitril/valsartan in the treatment of heart failure: protocol for a systematic review incorporating unpublished clinical study reports

    Article • HRB Open Research, February 2020, Faculty of 1000, Ltd.

    Frank Moriarty

  156. A comparison of contemporary versus older studies of aspirin for primary prevention

    Article • Family Practice, November 2019, Oxford University Press (OUP)

    Frank Moriarty

  157. Comparing Potentially Inappropriate Prescribing Tools and Their Association With Patient Outcomes

    Article • Journal of the American Geriatrics Society, November 2019, Wiley

    Frank Moriarty

  158. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non‐randomised pilot study

    Article • October 2019, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  159. Potentially serious alcohol–medication interactions and falls in community-dwelling older adults: a prospective cohort study

    Article • Age and Ageing, October 2019, Oxford University Press (OUP)

    Frank Moriarty

  160. Association of Antidepressants With Recurrent, Injurious and Unexplained Falls is Not Explained by Reduced Gait Speed

    Article • American Journal of Geriatric Psychiatry, October 2019, Elsevier

    Frank Moriarty

  161. A comparison of contemporary versus older studies of aspirin for primary prevention

    Article • August 2019, Cold Spring Harbor Laboratory Press

    Frank Moriarty

  162. Modification of Potentially Inappropriate Prescribing Following Fall-Related Hospitalizations in Older Adults

    Article • Drugs & Aging, March 2019, Springer Science + Business Media

    Frank Moriarty

  163. Prescriber Variation in Relation to Prescribing Trends within the Preferred Drugs Initiative in Ireland (2012–2015): An Interrupted Time-Series Study Using Latent Curve Models

    Article • Medical Decision Making, February 2019, SAGE Publications

    Frank Moriarty

  164. Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models

    Article • BMJ Open, January 2019, BMJ

    Frank Moriarty

  165. Prevalence of potentially inappropriate prescribing in older people in primary care and its association with hospital admission: longitudinal study

    Article • BMJ, November 2018, BMJ

    Frank Moriarty

  166. Self-report versus electronic medical record recorded healthcare utilisation in older community-dwelling adults: Comparison of two prospective cohort studies

    Article • PLOS One, October 2018, PLOS

    Frank Moriarty, Dr Christine McGarrigle

  167. Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron

    Article • Journal of Clinical Medicine, October 2018, MDPI AG

    Frank Moriarty

  168. The PIPc Study—application of indicators of potentially inappropriate prescribing in children (PIPc) to a national prescribing database in Ireland: a cross-sectional prevalence study

    Article • BMJ Open, October 2018, BMJ

    Frank Moriarty

  169. Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on Mirabegron

    Article • September 2018, MDPI AG

    Frank Moriarty

  170. Deprescribing guidelines: An international symposium on development, implementation, research and health professional education

    Article • Research in Social and Administrative Pharmacy, September 2018, Elsevier

    Frank Moriarty

  171. Deprescribing recommendations: An essential consideration for clinical guideline developers

    Article • Research in Social and Administrative Pharmacy, September 2018, Elsevier

    Frank Moriarty

  172. Deprescribing: Future directions for research

    Article • Research in Social and Administrative Pharmacy, September 2018, Elsevier

    Frank Moriarty

  173. Fixed-dose combination antihypertensives and risk of medication errors

    Article • Heart, August 2018, BMJ

    Frank Moriarty

  174. Supporting prescribing in Irish primary care: protocol for a non-randomised pilot study of a general practice pharmacist (GPP) intervention to optimise prescribing in primary care

    Article • Pilot and Feasibility Studies, July 2018, Springer Science + Business Media

    Frank Moriarty

  175. An evaluation of prescribing trends and patterns of claims within the Preferred Drugs Initiative in Ireland (2011–2016): an interrupted time-series study

    Article • BMJ Open, April 2018, BMJ

    Frank Moriarty

  176. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms

    Article • Expert Opinion on Drug Safety, November 2017, Taylor & Francis

    Frank Moriarty

  177. Potentially inappropriate prescribing and its association with health outcomes in middle-aged people: a prospective cohort study in Ireland

    Article • BMJ Open, October 2017, BMJ

    Frank Moriarty

  178. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot

    Article • Implementation Science, August 2017, Springer Science + Business Media

    Frank Moriarty

  179. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012

    Article • Journal of the American Geriatrics Society, November 2016, Wiley

    Frank Moriarty

  180. PIPc study: development of indicators of potentially inappropriate prescribing in children (PIPc) in primary care using a modified Delphi technique

    Article • BMJ Open, September 2016, BMJ

    Frank Moriarty

  181. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study

    Article • British Journal of Clinical Pharmacology, June 2016, Wiley

    Frank Moriarty

  182. Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria

    Article • European Journal of Clinical Pharmacology, January 2016, Springer Science + Business Media

    Frank Moriarty

  183. Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study

    Article • BMJ Open, September 2015, BMJ

    Frank Moriarty

  184. Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people

    Article • European Journal of Clinical Pharmacology, February 2015, Springer Science + Business Media

    Frank Moriarty

  185. Potentially Inappropriate Medicines and Potential Prescribing Omissions in Older People and Their Association With Health Care Utilization: A Retrospective Cohort Study

    Article • Value in Health, November 2014, Elsevier

    Frank Moriarty

  186. Potentially Inappropriate Prescribing and Vulnerability and Hospitalization in Older Community-Dwelling Patients

    Article • Annals of Pharmacotherapy, September 2014, SAGE Publications

    Frank Moriarty

  187. Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA)

    Article • European Journal of Clinical Pharmacology, February 2014, Springer Science + Business Media

    Frank Moriarty

  188. Potentially Inappropriate Prescribing (PIP) and Its Association with Instrumental Activities of Daily Living (IADL) Impairment in Older People

    Article • Value in Health, November 2013, Elsevier

    Frank Moriarty